期刊文献+

CD24 genetic variants contribute to overall survival inpatients with gastric cancer 被引量:3

CD24 genetic variants contribute to overall survival in patients with gastric cancer
下载PDF
导出
摘要 AIM: To investigate the role of single nucleotide polymorphisms(SNPs) in CD24 gene in susceptibility and overall survival of gastric cancer(GC).METHODS: We genotyped 3 tagging SNPs of CD24-P-534 in the promoter region, P170 in the coding region of exon 2 and P1527 in the 3′ untranslated region- using polymerase chain reaction-restriction fragment length polymorphism in specimens from 679 histologically-confirmed GC cases, 111 gastric atrophy(GA) cases and 976 tumor-free controls. Serumimmunoglobulin G antibodies to Helicobacter pylori(H. pylori) of all subjects were detected by enzyme-linked immunosorbent assay. CD24 expression was evaluated by immunohistochemistry in 131 GC specimens. Correlations between SNPs and risk of GC or GA were shown by P values and odd ratios(ORs) with 95% confidence intervals(95%CI) compared with the most common genotype of each SNP using the unconditional logistic regression model after adjusting for age, sex and H. pylori infection. Survival within each SNP group was plotted by Kaplan-Meier method and compared by log-rank test(recessive model). Hazard ratios with 95%CIs were computed by Cox regression model after adjusting for age, sex, histological type, tumor differentiation, clinical stage and post-operational chemotherapy.RESULTS: All of the three loci were in Hardy-Weinberg equilibrium in the control group. Median followup time for the 600 GC patients included in the survival analysis was 36.2 mo(range, 2.1-66.7 mo; 95%CI: 34.3-36.5 mo). Patients with the P-534 A/A genotype had significantly shorter survival(HR = 1.38, 95%CI: 1.01-1.88, P = 0.042) than did the C/C or C/A genotype carriers after adjusting for age, sex, histological type, tumor differentiation, clinical stage and post-operational chemotherapy. This trend was more evident in patients who lived longer than 2.5 years(HR = 7.55, 95%CI: 2.16-26.32, P = 0.001). The P170 T/T genotype was associated with a shorter lifespan than the non-T/T genotypes, but not significantly so. None of the three genetic variants was found to be associated with risk of GC(including tumor stage, grade and distant metastasis) or with risk of gastric atrophy. Furthermore, no difference of CD24 expression was found among the genotypes.CONCLUSION: The P-534 site in CD24 gene affects the overall survival of gastric cancer and may serve as a prognostic marker for gastric cancer. AIM: To investigate the role of single nucleotide polymorphisms(SNPs) in CD24 gene in susceptibility and overall survival of gastric cancer(GC).METHODS: We genotyped 3 tagging SNPs of CD24-P-534 in the promoter region, P170 in the coding region of exon 2 and P1527 in the 3′ untranslated region- using polymerase chain reaction-restriction fragment length polymorphism in specimens from 679 histologically-confirmed GC cases, 111 gastric atrophy(GA) cases and 976 tumor-free controls. Serumimmunoglobulin G antibodies to Helicobacter pylori(H. pylori) of all subjects were detected by enzyme-linked immunosorbent assay. CD24 expression was evaluated by immunohistochemistry in 131 GC specimens. Correlations between SNPs and risk of GC or GA were shown by P values and odd ratios(ORs) with 95% confidence intervals(95%CI) compared with the most common genotype of each SNP using the unconditional logistic regression model after adjusting for age, sex and H. pylori infection. Survival within each SNP group was plotted by Kaplan-Meier method and compared by log-rank test(recessive model). Hazard ratios with 95%CIs were computed by Cox regression model after adjusting for age, sex, histological type, tumor differentiation, clinical stage and post-operational chemotherapy.RESULTS: All of the three loci were in Hardy-Weinberg equilibrium in the control group. Median followup time for the 600 GC patients included in the survival analysis was 36.2 mo(range, 2.1-66.7 mo; 95%CI: 34.3-36.5 mo). Patients with the P-534 A/A genotype had significantly shorter survival(HR = 1.38, 95%CI: 1.01-1.88, P = 0.042) than did the C/C or C/A genotype carriers after adjusting for age, sex, histological type, tumor differentiation, clinical stage and post-operational chemotherapy. This trend was more evident in patients who lived longer than 2.5 years(HR = 7.55, 95%CI: 2.16-26.32, P = 0.001). The P170 T/T genotype was associated with a shorter lifespan than the non-T/T genotypes, but not significantly so. None of the three genetic variants was found to be associated with risk of GC(including tumor stage, grade and distant metastasis) or with risk of gastric atrophy. Furthermore, no difference of CD24 expression was found among the genotypes.CONCLUSION: The P-534 site in CD24 gene affects the overall survival of gastric cancer and may serve as a prognostic marker for gastric cancer.
出处 《World Journal of Gastroenterology》 SCIE CAS 2016年第7期2373-2382,共10页 世界胃肠病学杂志(英文版)
基金 National Natural Science Foundation of China,No.81373084 and No.81273065 the Norman Bethune Program of Jilin Universit,No.2013025 the Youth Fund of the First Hospital of Jilin University,No.JDYY42013014
关键词 GASTRIC cancer CD24 Single nucleotidepolymorphisms GASTRIC ATROPHY Overall survival Gastric cancer CD24 Single nucleotide polymorphisms Gastric atrophy Overall survival
  • 相关文献

参考文献43

  • 1Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C,Rebelo M, Parkin D, Forman D, Bray F. GLOBOCAN 2012 v1.0,Cancer Incidence and Mortality Worldwide: IARC CancerBaseNo. 11 [Internet]. Lyon, France: International Agency for Researchon Cancer 2013. Available from: URL: http://globocan.iarc.fr,accessed on 15/01/2015.
  • 2Schistosomes, liver flukes and Helicobacter pylori. IARC WorkingGroup on the Evaluation of Carcinogenic Risks to Humans. Lyon,7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994;61: 1-241 [PMID: 7715068].
  • 3Cao XY, Jia ZF, Jin MS, Cao DH, Kong F, Suo J, Jiang J. Serumpepsinogen II is a better diagnostic marker in gastric cancer. WorldJ Gastroenterol 2012; 18: 7357-7361 [PMID: 23326145 DOI:10.3748/wjg.v18.i48.7357].
  • 4Naumov I, Zilberberg A, Shapira S, Avivi D, Kazanov D,Rosin-Arbesfeld R, Arber N, Kraus S. CD24 knockout preventscolorectal cancer in chemically induced colon carcinogenesis andin APC(Min)/CD24 double knockout transgenic mice. Int J Cancer2014; 135: 1048-1059 [PMID: 24500912 DOI: 10.1002/ijc.28762].
  • 5Baumann P, Cremers N, Kroese F, Orend G, Chiquet-EhrismannR, Uede T, Yagita H, Sleeman JP. CD24 expression causes theacquisition of multiple cellular properties associated with tumorgrowth and metastasis. Cancer Res 2005; 65: 10783-10793 [PMID:16322224 DOI: 10.1158/0008-5472.can-05-0619].
  • 6Sagiv E, Starr A, Rozovski U, Khosravi R, Altevogt P, WangT, Arber N. Targeting CD24 for treatment of colorectal andpancreatic cancer by monoclonal antibodies or small interferingRNA. Cancer Res 2008; 68: 2803-2812 [PMID: 18413748 DOI:10.1158/0008-5472.can-07-6463].
  • 7Horiguchi K, Toi M, Horiguchi S, Sugimoto M, Naito Y, Hayashi Y,Ueno T, Ohno S, Funata N, Kuroi K, Tomita M, Eishi Y. Predictivevalue of CD24 and CD44 for neoadjuvant chemotherapy responseand prognosis in primary breast cancer patients. J Med Dent Sci2010; 57: 165-175 [PMID: 21073135].
  • 8Athanassiadou P, Grapsa D, Gonidi M, Athanassiadou AM,Tsipis A, Patsouris E. CD24 expression has a prognostic impact inbreast carcinoma. Pathol Res Pract 2009; 205: 524-533 [PMID:19243896 DOI: 10.1016/j.prp.2009.01.008].
  • 9Wang L, Liu R, Ye P, Wong C, Chen GY, Zhou P, Sakabe K,Zheng X, Wu W, Zhang P, Jiang T, Bassetti MF, Jube S, Sun Y,Zhang Y, Zheng P, Liu Y. Intracellular CD24 disrupts the ARFNPMinteraction and enables mutational and viral oncogenemediatedp53 inactivation. Nat Commun 2015; 6: 5909 [PMID:25600590 DOI: 10.1038/ncomms6909].
  • 10Sahlberg SH, Spiegelberg D, Glimelius B, Stenerl-w B, NestorM. Evaluation of cancer stem cell markers CD133, CD44, CD24:association with AKT isoforms and radiation resistance in coloncancer cells. PLoS One 2014; 9: e94621 [PMID: 24760019 DOI:10.1371/journal.pone.0094621].

同被引文献22

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部